Medical Director, Drug Safety and Pharmacovigilance
- Employer
- IDEAYA Biosciences
- Location
- South San Francisco, CA
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Administration, Clinical, Manufacturing & Production, Science/R&D, Training, Drug Safety/Pharmacovigilance, Safety, Pharmacology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Biotech Bay
By clicking apply, your email address will be shared with the employer.
Job Details
Non-Solicitation Policy and Notice to Agencies and Recruiters:
IDEAYA's Non-Solicitation Policy strictly prohibits agencies and recruiters from any contact and communication with IDEAYA employees, managers, and leaders to submit unsolicited candidate resumes and/or to solicit business partnerships. Submission of unsolicited candidate resumes by agencies or recruiters with or without a contract in place with IDEAYA Biosciences Inc. will not create any implied obligation. Failure to comply with this policy will result in disqualification from current and future business opportunities with IDEAYA Biosciences. All recruiting and talent agency decisions are strictly managed by the internal IDEAYA Human Resources function. All communication by external agencies and recruiters must be directed to humanresources@ideayabio.com. We ask that you only email your interest once.
Job Summary
Job Description
What you’ll do:
Serve as the primary medical expert who performs and oversees medical review of ICSRs, including complex, and medically significant cases in the oncology therapeutic area
Provide clinical assessment of adverse events, including causality, seriousness, expectedness, and review narrative content for clinical accuracy and flow
Act as the primary medical point of contact for the pharmacovigilance vendor for day-to-day ICSR-related questions and escalation
Provide medical input into vendor oversight activities, including case quality review, accuracy of triage, and regulatory submission compliance
Support development of medical review guidelines, training materials, and vendor-facing instructions
Collaborate closely with the IDEAYA Safety Operations team to ensure quality across global case processing activities by monitoring quality metrics and address non-compliance events
Conduct and oversee thorough investigations of quality events, deviations and CAPAs pertaining to case processing and regulatory compliance
Support development, implementation and tracking of CAPAs
Participate in vendor governance meetings as the medical representative
Support regulatory inspections, audits, and health authority inquiries related to ICSR processing and medical review
Contribute to the development and maintenance of SOPs and work instructions related to medical case review
Serve as the medical safety point of contact for any assigned molecule(s)
Provide safety input for aggregate safety reports, protocol amendments, investigator’s brochure, informed consent and other key regulatory safety documents.
Partner with Safety Science, Regulatory Affairs, and Clinical teams as needed on safety issues requiring medical input
Requirements:
MD (or equivalent international medical degree) with 2+ years of bedside clinical experience
5–8+ years of oncology experience in drug safety/pharmacovigilance
Strong hands-on ICSR medical review experience
Demonstrated experience working with external PV vendors or CROs
Solid knowledge of global PV regulations (FDA, EMA, ICH)
Strong medical judgment, attention to detail, and ability to work effectively in a matrix environment
All employees are expected to act with integrity and in full compliance with applicable laws, regulations, and IDEAYA policies, including IDEAYA’s Code of Conduct.
Employees must demonstrate good judgement and ethical behavior in all business activities, maintain patient and product safety as a top priority, and report any suspected violations of law or Company policy through appropriate channels
Total Rewards
Along with our inspiring mission, and highly collaborative and inclusive environment, IDEAYA offers a competitive total rewards package that reflects our pay-for-performance philosophy where employees are eligible to be considered for merit-based salary increases, company discretionary short-term incentive plan participation, and company discretionary stock option awards (based on board approval). Our comprehensive benefits package includes, but is not limited to, medical/dental/vision coverage (100% company paid for employees and 90% company paid for dependents), 401k, ESPP, and wellness programs.
The expected salary range for the roleof Medical Director, Drug Safety and Pharmacovigilance is $268,000 - $331,000. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the office location where this open position is located, the final candidates’ experience within their profession, experience in the disease areas we are striving to make an impact in as a company, length of time within the industry, educational background, and performance during the interview process.
The Company complies with all laws respecting equal employment opportunities and does not discriminate against applicants with regard to any protected characteristic as defined by federal, state, and local law.
IDEAYA is an equal opportunity employer. In accordance with applicable law, IDEAYA does not discriminate in hiring or otherwise in employment based on race, color, religion, sex, national origin, age, marital or veteran status, disability, sexual orientation, or any other legally protected status. EOE/AA/Vets.
We are committed to providing reasonable accommodations to qualified individuals with disabilities. If you need assistance or an accommodation due to a disability, please get in touch with us at hr@ideayabio.com.
Company
Founded in 2015, IDEAYA Biosciences is a public, clinical-stage synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using DNA sequencing and other molecular diagnostics. Our approach integrates extensive capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the therapies we are developing. We are applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets. We believe this diversified approach will enable us to deliver the right medicine to the right patient to drive a more robust clinical response.
Stock Symbol: IDYA
- Phone
- 650-443-6209
- Location
- 5000 Shoreline Court, Ste. 300
South San Francisco
California
94080